Local Adjuvant Substances Following Curettage of Bone Tumors

J Bone Joint Surg Am. 2020 Jan 15;102(2):164-174. doi: 10.2106/JBJS.19.00470.

Authors

Jacob Bickels¹, Domenico A Campanacci²

Affiliations

¹ Unit of Orthopedic Oncology, Orthopedic Division, Hillel-Yaffe Medical Center, Hadera, Rappaport Faculty of Medicine, The Technion, Israel.
² Unit of Orthopaedic Oncology, Department of Health Sciences, Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy.

PMID: 31613863
DOI: 10.2106/JBJS.19.00470

No abstract available

Publication types

Review

MeSH terms

Anti-Infective Agents, Local / therapeutic use
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Argon Plasma Coagulation / methods
Bone Cements / therapeutic use
Bone Neoplasms / drug therapy
Bone Neoplasms / surgery*
Chemotherapy, Adjuvant
Cryosurgery / methods
Curettage / methods*
Giant Cell Tumor of Bone / drug therapy
Giant Cell Tumor of Bone / surgery*
Humans
Neoplasm Recurrence, Local
Phenol / therapeutic use
Polymethyl Methacrylate / therapeutic use
Postoperative Complications / drug therapy
Postoperative Complications / etiology

Substances

Anti-Infective Agents, Local
Bone Cements
Phenol
Polymethyl Methacrylate